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S U M M A R Y
Objective: This study was designed to evaluate the antigen capture enzyme immunoassays (EIAs) Triage
parasite panel and TechLab Entamoeba histolytica II in detecting Giardia intestinalis, Cryptosporidium sp,
and Entamoeba histolytica in fecal samples in comparison to microscopy, and in differentiating
Entamoeba histolytica from Entamoeba dispar.
Methods: The Triage EIA was evaluated using 100 stool specimens that were tested by standard ova and
parasite examination, including staining with both trichrome and modiﬁed acid-fast stains.
Differentiation between E. histolytica and E. dispar was performed using TechLab.
Results: Microscopic examination revealed that 19% of the samples were positive for Giardia, 4% for
Cryptosporidium, and 1% for E. histolytica/E. dispar, and other parasites were found in 5%. By Triage, 23%
of the samples were infected with Giardia, 5% with Cryptosporidium, and 2% with E. histolytica/E. dispar.
Triage showed a sensitivity of 100% and speciﬁcity of 91.5%. The TechLab assay was negative for both
samples diagnosed as E. histolytica/E. dispar by Triage, which suggested that they were E. dispar. Both
tests showed no cross-reactivity with other intestinal protozoa.
Conclusion: These results indicate that antigen detection by EIA has the potential to become a valuable
tool, capable of making stool diagnostics more effective.
 2011 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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jou r nal h o mep ag e: w ww .e lsev ier . co m / loc ate / i j id1. Introduction
Diarrheal disease is one of the leading causes of morbidity and
mortality worldwide. The intestinal protozoa most commonly
causing gastroenteritis are Giardia intestinalis and Cryptosporidium
sp, together with Entamoeba histolytica, and the clinical presenta-
tion of these protozoal infections is often similar.1,2 To complicate
matters further, symptoms may also be similar to those caused by
other gastrointestinal pathogens, such as those of bacterial and
viral gastroenteritis.3,4
Traditionally, the diagnosis of these infections has relied upon
direct microscopic detection of cysts, trophozoites, or oocysts in
fresh or ﬁxed stool specimens. However, these methods are
laborious, time-consuming, and require expertise.5,6 Moreover, for
biological reasons such as the intermittent pattern of cyst or
trophozoite excretion, sensitivities greater than 90% are rarely
obtained.7 The sensitivity of parasite identiﬁcation has been
reported to increase up to 85% when microscopic examination is
performed on three fecal samples obtained on different days.7,8
However, this leads to problems concerning patient compliance
and delays in the ﬁnal diagnosis. On the other hand, diagnosis of* Corresponding author. Tel.: +00966500300230; fax: +0096612790232.
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doi:10.1016/j.ijid.2011.04.004these parasites could be made using duodenal aspirates, duodenal
smears, or intestinal biopsies. In contrast to duodenal aspirates and
biopsy samples, which require invasive and rather costly
procedures, fecal samples can be readily obtained, and are thus
the best sample available for parasite identiﬁcation.6,8
Previous studies have conﬁrmed the existence of two geneti-
cally distinct but morphologically indistinguishable species of
Entamoeba: E. histolytica and E. dispar. E. histolytica is the
pathogenic and the etiologic agent of amoebic colitis and liver
abscess, while E. dispar is a non-pathogenic species and has seldom
been associated with disease, hence treatment is unnecessary.
Differentiation between the two species is essential both for
treatment decisions and public health knowledge.9,10 Techniques
such as isoenzyme analysis and PCR can accurately distinguish
between the species, but such techniques are not practical for
routine use in developing nations where E. histolytica is preva-
lent.11–13
Antigen detection assays have been developed in an attempt to
establish sensitive and cost-effective methods to diagnose
intestinal parasitic infections. Some assays are thought to have
signiﬁcant advantages for the detection of G. intestinalis, Crypto-
sporidium, and E. histolytica/E. dispar in stool samples, while others
are able to differentiate between E. histolytica and E. dispar.6,14,15
Studies have suggested that stool antigen assays offer an
alternative to the routine ova and parasite (O&P) examinationses. Published by Elsevier Ltd. All rights reserved.
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the need for speciﬁc expertise and they provide the added
sensitivity required to conﬁrm infections in patients with low
parasite numbers.15,16
A number of products are commercially available and have
been evaluated. These assays range in sensitivity from 66.3% to
100% and in speciﬁcity from 92.6% to 100%.13,17,18
The aim of the present study was to evaluate the utility of the
antigen capture enzyme immunoassays (EIAs) in detecting G.
intestinalis, Cryptosporidium, and Entamoeba in fecal samples from
patients attending the outpatient clinic of Alexandria University,
and to differentiate E. histolytica from E. dispar in order to avoid
unnecessary treatment with amebicidal drugs.
2. Materials and methods
A total of 108 stool specimens were collected from patients
attending the outpatient clinic of Alexandria University, who
presented with abdominal symptoms, mainly diarrhea, from April
to September 2010. Written informed consent was obtained from
each patient. Eight of the 108 samples collected were excluded
from the study because of the existence of other associated medical
problems. Thus 100 fresh stool specimens were tested at the
Diagnostic Laboratory of the Parasitology Department, Alexandria
University, Egypt.
All specimens were processed separately. One aliquot of each
sample was immediately preserved in 10% formalin and was
submitted to direct wet saline smear, iodine smear, and formol–
ether concentration method. Ten microliters of each concentrated
specimen was smeared on a slide and allowed to air-dry. Staining
by trichrome stain and modiﬁed Ziehl–Neelsen (MZN) was
performed according to the manufacturer’s instructions, with
the aim of identifying Giardia and E. histolytica trophozoites or
cysts, Cryptosporidium oocysts (which appear as spherical
organisms of 4–6 mm in size and contain four sporozoites), or
any other parasitic infection.8,19
A second aliquot of each stool specimen was immediately
frozen and stored at 20 8C. Subsequently, the frozen aliquots
were thawed before testing with the EIAs.9,18
Whatever the result of the O&P examinations of the ﬁrst aliquot
of each sample – positive or negative or uncertain for parasites –
the second aliquot of the same sample was tested by the EIA
techniques. In this study, two assays were used, the ﬁrst was the
Triage parasite panel enzyme immunoassay (Triage) and the
second was the TechLab Entamoeba histolytica II.
This study was approved by the Ethics Committee of Alexandria
University.
2.1. The Triage parasite panel enzyme immunoassay (Biosite
Diagnostics, CA, USA)18,20
This is a qualitative enzyme immunoassay panel, in which a
single immunochromatographic strip is coated with monoclonal
antibodies speciﬁc for E. histolytica/E. dispar antigen (29 kDa
surface antigen), G. intestinalis antigen (alpha-1-giardin), and
Cryptosporidium antigen (protein disulﬁde isomerase). The assay
was carried out as recommended by the manufacturer. In brief, the
assay procedure involved the addition of 4.5 ml of specimen
diluent to the specimen tube. Stool sample (0.5 ml) was added, and
the mixture was vortexed for at least 10 s. This diluted, mixed
sample was centrifuged at 1500  g for at least 5 min. The sample
supernatant was poured into the sample ﬁlter device and was
ﬁltered into the ﬁltrate tube. The ﬁltered sample (0.5 ml) was then
added to the center of the detection zone of the test device with a
transfer pipette. One hundred and forty microliters of enzyme
conjugate (alkaline phosphatase) was added to the center of themembrane and this was then incubated for 3 min at room
temperature. Six drops of wash solution (buffered solution) were
added to the membrane. Next, four drops of the substrate (indoxyl
phosphate) were added to the membrane, followed by 5 min
incubation at 15–25 8C. The device was then read and the results
were interpreted (test zones, three positive control (POS CTRL)
zones and one negative control (NEG CTRL) zone). Positive results
were visualized as purple–black lines in the appropriate position in
the results window. The tubes, pipettes, devices, and all reagents
were provided with the kit. Positive and negative controls were
included in the device, and the total test time was approximately
15 min.
All stool specimens diagnosed as being either E. histolytica or E.
dispar by the Triage parasite panel assay were retested by the
second assay, namely the TechLab Entamoeba histolytica II. This
assay was used to differentiate between E. histolytica and E. dispar.
2.2. The TechLab Entamoeba histolytica II (TechLab, Blacksburg, VA,
USA)16,17,21
This kit is speciﬁc and sensitive for the detection of E. histolytica
in feces. It is an antigen detection assay that captures and detects
the parasite’s Gal/GalNAc lectin from stool samples. For the
TechLab E. histolytica II test, the assay was carried out as suggested
by the manufacturer. In brief, all stool specimens were diluted 1:1
in diluents provided with the kit. The assay microtiter wells
(provided with the kit) were incubated with 200 ml of diluted
specimen and one drop of mAb–enzyme conjugate (monoclonal
antibodies coupled to horseradish peroxidase). Positive and
negative controls were included in each test. After 2 h of
incubation at 15–25 8C, the liquid in the well was decanted and
was washed ﬁve times with phosphate buffered saline. Following
washing, the residual ﬂuid was removed by striking the inverted
plate on a paper towel. One drop of substrate (tetramethylbenzi-
dine (TMB)) was added and the wells were incubated for 10 min at
room temperature. Finally, a drop of stop solution (sulfuric acid
1.0 M) was added to prepare the liquid for measurement on an
ELISA reader at 450 nm. A positive result was deﬁned as an optical
density reading of 0.050 or higher.
2.3. Statistical analysis
The percentages of positive cases detected by microscopy and
the EIA techniques were calculated. Furthermore, the sensitivity,
speciﬁcity, negative predictive value (NPV), and positive predictive
value (PPV) of the Triage test were calculated in accordance with
Knapp and Miller.22
3. Results
A total of 100 stool specimens were collected, 32 from females
and 68 from males. Of the 100 specimens examined microscopi-
cally, 29 were positive for the following parasites on the basis of
the results of the reference methods: G. intestinalis (n = 19),
Cryptosporidium (n = 4), E. histolytica/E. dispar (n = 1); other
intestinal parasites were diagnosed by microscopy of concentrated
specimens in ﬁve samples (Blastocystis hominis (n = 1), Cyclospora
cayetanensis (n = 1), both Iodamoeba bu¨tschlii and Blastocystis
hominis (n = 1), and both Escherichia coli and Blastocystis hominis
(n = 2)) (Table 1).
The Triage test could not diagnose any parasite other than G.
intestinalis, Cryptosporidium, and E. histolytica/E. dispar. The Triage
test accurately detected 30 positive samples, with no cross-
reactivity with other intestinal protozoa. Twenty-three samples
were G. intestinalis, ﬁve samples were Cryptosporidium, and two
samples were E. histolytica/E. dispar (Table 1). All cases of G.
Table 1




Giardia intestinalis Cryptosporidium Other parasites
detected by MP
Total infected Total
MP Triage MP Triage MP Triage MP Triage
Females 1 1 8 9 1 1 2 12 11 32
Males 0 1 11 14 3 4 3 17 19 68
Total 1 2 19 23 4 5 5 29 30 100
Percentage 1% 2% 19% 23% 4% 5% 5% 29% 30% 100%
Table 2
Results of the diagnostic procedures used for the detection of Giardia,
Cryptosporidium and Entamoeba histolytica/Entamoeba dispar in stool specimens





Total number of positive cases 24 6 30
Total number of negative cases 0 65 65
Total 24 71 95
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microscopy were also positive by Triage parasite panel kit, thus
they were considered truly positive. Four cases of Giardia, one of
Cryptosporidium, and one of E. histolytica/E. dispar were positive in
the Triage test, but negative by microscopy (Table 2). When
microscopy was used as the reference standard, the sensitivity,
speciﬁcity, negative and positive predictive values of the Triage
test were 100%, 91.5%, 100%, and 80%, respectively.
Differentiation between E. histolytica and E. dispar was
performed using TechLab Entamoeba histolytica II. The assay
showed that the two samples diagnosed positive for E. histolytica/E.
dispar by the Triage parasite panel kit were negative for E.
histolytica antigen, which suggested that they were E. dispar.
TechLab showed no cross-reactivity with other intestinal protozoa.
4. Discussion
The purpose of parasite detection is not limited to curing the
disease in an infected individual, but is also crucial in the
prevention and spread of diseases. For these reasons, detection
methods must be held at the highest standard of both sensitivity
and speciﬁcity, so that false-negative and false-positive results are
avoided.3
In this study, on the basis of the results of O&P examination
with both trichrome and modiﬁed acid-fast stains, and the results
of the commercial EIA (Triage), it is clear that the routine
microscopy methods did not reveal as many positive specimens
as the immunoassay technique. Furthermore, the Triage qualita-
tive EIA was simple and rapid, it was performed in approximately
15 min with fresh, frozen, unﬁxed human fecal specimens, and its
sensitivity and speciﬁcity were 100% and 91.5%, respectively. These
results are in accordance with those of Rosoff et al.,23 who showed
that the Giardia EIA can detect Giardia in at least 30% more
specimens than microscopic examination; they also reported a
sensitivity and speciﬁcity of 98% and 100%, respectively. Moreover,
similar ﬁndings were obtained by Garcia et al.,18 who stated that
the Triage parasite panel procedure was easy to perform and
required minimal training; they reported sensitivity and speciﬁcity
for all detected parasites ranging from 95.9% up to 99.7%. In
addition, they suggested that this procedure could provide
diagnostic laboratories with a simple, convenient, alternative
method for performing simultaneous, discrete detection of Giardia,
Cryptosporidium, and E. histolytica/E. dispar speciﬁc antigens inpatient fecal specimens. Furthermore, our results are also
supported by the study of Beltra´n et al.,7 who stated that the
EIA for stool antigen detection was easy to perform and allows
simultaneous processing of multiple samples.
Direct microscopic examination is undoubtedly the gold
standard for the diagnosis of parasitic diseases, moreover it has
the advantage of being inexpensive compared to antigen detection
tests. Nevertheless, accurate identiﬁcation of intestinal parasites
mostly depends on the proﬁciency of the microscopist and on
interpretation. Results of microscopic examination can therefore
differ between studies according to staff experience, as well as the
techniques used for diagnosis, and may be prone to error. However,
Beltra´n et al.,7 suggested that the cost of the parasitological
diagnosis by means of examination of multiple fecal samples is
similar to that of the EIA antigen detection assay. Also, Garcia
et al.18 and Tanyuksel and Petri13 stated that these assays have
many advantages, including labor, time, and batching efﬁciencies
that may lead to cost reductions.
Sensitive and speciﬁc detection of E. histolytica infection is
required in order to ensure that patients receive the proper
treatment. The classical method for diagnosis has been microsco-
py, although this test does not discriminate between E. histolytica
and E. dispar.21 Several sophisticated techniques are available for
differentiation of these two related species, such as PCR, real-time
PCR, and isoenzyme characterization. However, DNA extraction
from fecal specimens and PCR remain expensive and require
skilled technicians.17,24 Therefore, commercially available EIAs
may currently represent the most practical method for the
identiﬁcation of E. histolytica in stool samples.25
In the present study, the EIA technique, namely TechLab E.
histolytica II, indicated that the two samples previously diagnosed
as being positive for E. histolytica/E. dispar by the Triage test, were
negative for E. histolytica antigen, which suggested that they were
E. dispar. The ﬁndings of the present work were consistent with
those previously reported by Lebbad and Svard.26 They showed a
high incidence of E. dispar (non-pathogenic amoeba) among
Entamoeba infections in the population. Our results are also
supported by the study of Redondo et al.21 They suggested that
whenever an alternative method to microscopic examination was
used to differentiate the two types of ameba, the majority were E.
dispar.
The TechLab Entamoeba histolytica II was easy to perform,
sensitive, and relatively quick. This is in accordance with Delalioglu
et al.27 and Zeehaida et al.,28 who reported that the ELISA for E.
histolytica fecal antigens permitted rapid detection and could be
used for specimens submitted for routine clinical testing from
adults or children. In addition, they identiﬁed the test to be a highly
sensitive technique: as little as 0.2–0.4 ng of parasitic antigen
could be detected from stool samples. Indeed, it has been shown to
be as sensitive and speciﬁc as culture with isoenzyme analysis.
Overall, the results of the present study show that EIAs are
sensitive and speciﬁc for antigen detection in human fecal eluates.
They might be useful additions for the diagnosis of giardiasis,
cryptosporidiosis, and amebiasis, and for differentiating E.
M.R. Gaafar / International Journal of Infectious Diseases 15 (2011) e541–e544e544histolytica from E. dispar. When applied under ﬁeld conditions, they
would help to determine the true prevalence of these parasitic
infections in large-scale screening studies for future decisions on
treatment.
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